TY - JOUR
T1 - Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma
T2 - a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation
AU - Pettengell, Ruth
AU - Schmitz, Norbert
AU - Gisselbrecht, Christian
AU - Smith, Graeme
AU - Patton, William N
AU - Metzner, Bernd
AU - Caballero, Dolores
AU - Tilly, Herve
AU - Walewski, Jan A
AU - Bence-Bruckler, Isabelle
AU - To, Bik
AU - Geisler, Christian H
AU - Schots, Rik
AU - Kimby, Eva
AU - Taverna, Christian J
AU - Kozák, Tomás
AU - Dreger, Peter
AU - Uddin, Ruzena
AU - Ruiz de Elvira, Carmen
AU - Goldstone, Anthony H
PY - 2013/5/1
Y1 - 2013/5/1
N2 - The objective of this randomized trial was to assess the efficacy and safety of rituximab as in vivo purging before transplantation and as maintenance treatment immediately after high-dose chemotherapy and autologous stem-cell transplantation (HDC-ASCT) in patients with relapsed follicular lymphoma (FL).
AB - The objective of this randomized trial was to assess the efficacy and safety of rituximab as in vivo purging before transplantation and as maintenance treatment immediately after high-dose chemotherapy and autologous stem-cell transplantation (HDC-ASCT) in patients with relapsed follicular lymphoma (FL).
KW - Adult
KW - Aged
KW - Antibodies, Monoclonal, Murine-Derived
KW - Antineoplastic Agents
KW - Bone Marrow Purging
KW - Combined Modality Therapy
KW - Female
KW - Humans
KW - Lymphoma, Follicular
KW - Male
KW - Middle Aged
KW - Prospective Studies
KW - Recurrence
KW - Salvage Therapy
KW - Stem Cell Transplantation
KW - Transplantation, Autologous
U2 - 10.1200/JCO.2012.47.1862
DO - 10.1200/JCO.2012.47.1862
M3 - Journal article
C2 - 23547078
SN - 0732-183X
VL - 31
SP - 1624
EP - 1630
JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
IS - 13
ER -